September 6, 2018 09:37 AM EDT
Pharma

GSK chops 650 jobs, vow­ing to shift more mon­ey to a weak R&D ef­fort

John Carroll

Editor & Founder

Glax­o­SmithK­line $GSK has once again brought out the axe, chop­ping 650 jobs as the phar­ma gi­ant slow­ly looks to fun­nel more mon­ey to the R …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Ku­ra's AML drug pass­es key study in ad­vanced pa­tients, plans next steps with FDA and new­ly di­ag­nosed stud­ies

Small per­son­al­ized vac­cine tri­al sees progress in late-stage kid­ney can­cer

Eye­Point shares more mid-stage da­ta for ther­a­py try­ing to com­pete with Re­gen­eron's Eylea

Bris­tol My­ers, Ky­owa Kirin dis­close lay­offs

A service from the Financial Times